- News Home
6 March 2014 1:04 pm ,
Vol. 343 ,
Antiretroviral drugs can protect people from becoming infected by HIV. But so-called pre-exposure prophylaxis, or PrEP...
Two studies show that eating a diet low in protein and high in carbohydrates is linked to a longer, healthier life, and...
Considered an icon of conservation science, researchers at World Wildlife Fund (WWF) headquarters in Washington, D.C.,...
The new atlas, which shows the distribution of important trace metals and other substances, is the first product of...
Early in April, the first of a fleet of environmental monitoring satellites will lift off from Europe's spaceport in...
Since 2000, U.S. government health research agencies have spent almost $1 billion on an effort to churn out thousands...
Magdalena Koziol, a former postdoc at Yale University, was the victim of scientific sabotage. Now, she is suing the...
- 6 March 2014 1:04 pm , Vol. 343 , #6175
- About Us
NIH Program on Undiagnosed Diseases Overwhelmed With Cases
1 July 2011 12:13 pm
The National Institutes of Health's (NIH's) high-profile initiative to diagnose mystery illnesses is pausing to catch its breath.
The Undiagnosed Diseases Program was started in 2008 to help people desperate for diagnosis and to use the discovery of novel diseases to learn more about human biology. But as of today, the program will temporarily stop accepting new applications for cases to be studied because of an "overwhelming number of applications already received," according to the note posted on the program's Web site.
"We've been flooded for a while. This is a last-ditch effort to catch up," says the program's head William Gahl, a biochemical geneticist at the National Human Genome Research Institute. "We want to be able to devote more time to the conditions we've already seen."
The Undiagnosed Diseases Program has received some 5400 inquiries, and a full application, with the medical records of the ill person, were submitted on about 1900, according to Gahl. The program has so far accepted around 450 of those applicants, but has had time to only investigate about 350 cases so far—each person typically comes in for about a week of studies at the clinical center on NIH's Bethesda, Maryland, campus. Gahl says that applications already submitted will still be considered for such a full investigation. And he hopes the program, which published its first discovery of a new genetic disorder earlier this year, will resume accepting new case applications in a few months.